Zymeworks (ZYME) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.62
- EPS estimate
- −$0.57
- EPS surprise
- −9.23%
- Revenue surprise
- +20.35%
- Revenue
- $4.6M
- Revenue estimate
- $3.8M
- Reported
- Aug 6, 2026
Zymeworks reported Q2 2026 results on August 6, 2026. It posted a loss of $0.62 per share, wider than the $0.57 loss analysts expected, a miss of 9.23%. Revenue was $4.6 million, above the $3.8 million estimate. A year earlier, in Q2 2025, it earned $0.03 per share on $48.7 million in revenue.
The longer record is mostly losses with uneven revenue. Zymeworks was profitable in only two of the last 20 quarters: Q4 2022, the high in the table at $4.65 per share on $402.5 million in revenue, and Q2 2025. Full-year 2022 showed a profit of $1.77 per share. The years since were losses: $1.74 per share in 2023, $1.61 in 2024 and $1.08 in 2025. Revenue has dropped sharply in the last three quarters, to between $2.4 million and $4.6 million, and the first half of 2026 brought $7.0 million against $75.8 million a year earlier. Over the last 20 quarters, Zymeworks beat the EPS estimate 11 times and missed nine times, including the last three.
Zymeworks reported Q3 between October 31 and November 8 in each of the past five years. That points to late October or early November 2026 for the next report.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | −$0.57 | −$0.62 | −9.23% | $4.6M | SEC |
| Q1 2026 | May 7, 2026 | −$0.30 | −$0.59 | −98.79% | $2.4M | SEC |
| Q4 2025 | Mar 2, 2026 | −$0.46 | −$0.55 | −19.28% | $2.5M | SEC |
| Q3 2025 | Nov 6, 2025 | −$0.29 | −$0.26 | +11.77% | $27.6M | SEC |
| Q2 2025 | Aug 7, 2025 | −$0.48 | $0.03 | +106.22% | $48.7M | SEC |
| Q1 2025 | May 8, 2025 | −$0.68 | −$0.30 | +56.11% | $27.1M | SEC |
| Q4 2024 | Mar 5, 2025 | −$0.10 | −$0.31 | −211.87% | $31.0M | SEC |
| Q3 2024 | Oct 31, 2024 | −$0.40 | −$0.39 | +1.71% | $16.0M | SEC |
| Q2 2024 | Aug 1, 2024 | −$0.42 | −$0.49 | −17.37% | $19.2M | SEC |
| Q1 2024 | May 2, 2024 | −$0.32 | −$0.42 | −30.43% | $10.0M | SEC |
| Q4 2023 | Mar 6, 2024 | −$0.41 | −$0.20 | +51.77% | $16.9M | SEC |
| Q3 2023 | Nov 7, 2023 | −$0.47 | −$0.41 | +12.65% | $16.5M | SEC |
| Q2 2023 | Aug 10, 2023 | −$0.47 | −$0.76 | −61.56% | $7.0M | SEC |
| Q1 2023 | May 8, 2023 | −$0.54 | −$0.37 | +30.98% | $35.6M | SEC |
| Q4 2022 | Mar 7, 2023 | $1.43 | $4.65 | +226.22% | $402.5M | SEC |
| Q3 2022 | Nov 8, 2022 | −$0.94 | −$0.72 | +23.29% | $2.6M | SEC |
| Q2 2022 | Aug 4, 2022 | −$0.95 | −$0.97 | −1.63% | $5.4M | SEC |
| Q1 2022 | May 4, 2022 | −$0.98 | −$1.19 | −21.28% | $1.9M | SEC |
| Q4 2021 | Feb 24, 2022 | −$1.14 | −$0.95 | +16.75% | $19.9M | SEC |
| Q3 2021 | Nov 3, 2021 | −$1.26 | −$1.25 | +0.96% | $4.4M | SEC |
Quarterly revenue
Frequently asked questions
When did Zymeworks (ZYME) last report earnings?
Zymeworks last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did ZYME beat earnings estimates?
No. Zymeworks reported EPS of −$0.62 for Q2 2026 against a −$0.57 estimate — a 9.23% miss.
How much revenue did ZYME report last quarter?
Zymeworks reported $4.6M in revenue for Q2 2026, against a consensus estimate of $3.8M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.